Mariam Masri, NP
Nurse Practitioner · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Mariam Masri’s office at (650) 723-4000 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$11,218
Medicare paid this office $11,218 for 77 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit | 15 | $757 | $47 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $392 | $21 |
Procedures Medicare counted
| Laminectomy or laminotomy (partial removal of spine bones) | 1-10 | None |
Who their Medicare patients are
77 Original Medicare patients in 2024. Average age 74 · Women 44% · Also on Medicaid 40% · Health risk score 1.45. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Depression 36% · Diabetes 31% · Coronary heart disease 22% · Chronic kidney disease 21% · Stroke 18% · Atrial fibrillation 17% · Cancer 14%.
The office billed $59,961, Medicare allowed $14,391 and paid $11,218; for 145 services of 36 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 77 | 145 | 74 | 1.45 | $59,961 | $11,218 |
| 2023 | 27 | 77 | 73 | 1.16 | $37,005 | $6,431 |
| 2022 | 64 | 200 | 72 | 1.49 | $94,928 | $17,195 |
| 2021 | 26 | 35 | 73 | 1.07 | $22,749 | $4,577 |
| 2020 | 147 | 367 | 76 | 1.82 | $86,846 | $14,361 |
| 2019 | 52 | 59 | 73 | 1.56 | $28,826 | $4,789 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Short return visit (20+ min) | 18 | $1,538 | $73 |
2020: 3 services
| Return visit (30+ min) | 110 | $9,034 | $76 |
| New patient visit (60+ min) | 12 | $1,970 | $164 |
| Short return visit (20+ min) | 21 | $1,203 | $55 |
2019: 1 service
| Return visit (30+ min) | 44 | $3,756 | $82 |
Medicaid work
$710 in 2019
Medicaid paid $710 for 30 billed services this clinician did in 2019, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 15 | $703 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 15 | $7 |
| 2019 | 30 | 2 | 15 | $710 |
Drugs they prescribed that Part D paid
$689
Pharmacies billed $689 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 32% of their Part D prescriptions (20 of 63) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
63 generic and 0 brand-name prescriptions · $689 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 12 | $209 | $11 |
Year by year
| 2024 | 63 | 41 | 32% (20) | 0% | $689 |
| 2023 | 78 | 34 | 45% (35) | None | $996 |
| 2022 | 73 | 45 | 45% (33) | None | $2,948 |
| 2021 | 335 | 126 | None | 20% | $58,581 |
| 2020 | 1,647 | 341 | None | 13% | $162,714 |
| 2019 | 993 | 245 | None | None | $72,971 |
| 2018 | 43 | None | 0% (0) | 53% | $36,397 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Gabapentin | 12 | $281 | $23 |
| Baclofen | 12 | $136 | $11 |
| Oxycodone | 14 | $78 | $6 |
2022: 2 drugs
| Gabapentin | 14 | $266 | $19 |
| Hydrocodone-Acetaminophen | 11 | $65 | $6 |
2021: 9 drugs
| Eliquis | 31 | $19,511 | $629 |
| Atorvastatin | 66 | $806 | $12 |
| Levetiracetam | 12 | $503 | $42 |
| Clopidogrel | 21 | $323 | $15 |
| Gabapentin | 14 | $290 | $21 |
| Venlafaxine Hcl Er | 15 | $264 | $18 |
| Rosuvastatin | 11 | $227 | $21 |
| Duloxetine | 11 | $207 | $19 |
| Donepezil | 20 | $176 | $9 |
2020: 34 drugs
| Eliquis | None | 84 | $57,532 | $685 |
| Vimpat | None | 17 | $13,713 | $807 |
| Xarelto | None | 18 | $13,287 | $738 |
| Emgality | Migraine | 14 | $10,258 | $733 |
| Aimovig | Migraine | 17 | $10,024 | $590 |
| Brilinta | None | 13 | $6,055 | $466 |
| Atorvastatin | None | 304 | $4,497 | $15 |
| Rosuvastatin | None | 63 | $2,005 | $32 |
| Clopidogrel | None | 119 | $1,904 | $16 |
| Mirtazapine | None | 19 | $1,820 | $96 |
| Memantine | None | 47 | $1,769 | $38 |
| Donepezil | None | 78 | $1,656 | $21 |
| Gabapentin | None | 67 | $1,427 | $21 |
| Topiramate | None | 52 | $1,420 | $27 |
| Oxcarbazepine | None | 16 | $1,309 | $82 |
| Levetiracetam | None | 51 | $1,186 | $23 |
| Carbidopa-Levodopa | None | 28 | $1,156 | $41 |
| Duloxetine | None | 65 | $999 | $15 |
| Rizatriptan | None | 38 | $900 | $24 |
| Lamotrigine | None | 22 | $606 | $28 |
| Pramipexole Dihydrochloride | None | 13 | $570 | $44 |
| Divalproex Sodium Er | None | 13 | $562 | $43 |
| Escitalopram | None | 44 | $521 | $12 |
| Clonazepam | None | 24 | $361 | $15 |
| Lidocaine | None | 18 | $300 | $17 |
| Famotidine | None | 14 | $253 | $18 |
| Lisinopril | None | 35 | $233 | $7 |
| Amlodipine Besylate | None | 31 | $232 | $7 |
| Metoprolol | None | 18 | $124 | $7 |
| Losartan | None | 16 | $117 | $7 |
| Nortriptyline | None | 15 | $100 | $7 |
| Hydrochlorothiazide | None | 21 | $84 | $4 |
| Diazepam | None | 18 | $74 | $4 |
| Meclizine | None | 12 | $52 | $4 |
2019: 22 drugs
| Eliquis | 37 | $20,928 | $566 |
| Atorvastatin | 185 | $3,078 | $17 |
| Donepezil | 69 | $1,904 | $28 |
| Rosuvastatin | 33 | $1,436 | $44 |
| Gabapentin | 46 | $1,367 | $30 |
| Clopidogrel | 87 | $1,260 | $14 |
| Duloxetine | 28 | $1,055 | $38 |
| Carbidopa-Levodopa | 35 | $948 | $27 |
| Levetiracetam | 40 | $775 | $19 |
| Pramipexole Dihydrochloride | 16 | $727 | $45 |
| Divalproex Sodium Er | 11 | $583 | $53 |
| Topiramate | 30 | $554 | $18 |
| Memantine | 14 | $532 | $38 |
| Carbidopa-Levodopa Er | 13 | $438 | $34 |
| Escitalopram | 27 | $318 | $12 |
| Famotidine | 16 | $208 | $13 |
| Lisinopril | 19 | $144 | $8 |
| Hydrochlorothiazide | 26 | $142 | $5 |
| Amlodipine Besylate | 20 | $110 | $5 |
| Losartan | 12 | $60 | $5 |
| Clonazepam | 12 | $39 | $3 |
| Diazepam | 12 | $38 | $3 |
2018: 1 drug
| Truvada | 11 | $19,070 | $1,734 |
Money from drug and device companies
$386 in 2025
| 2025 | 3 | 9 | None | $386 |
| 2024 | 2 | 7 | None | $287 |
| 2022 | 2 | 2 | None | $43 |
| 2021 | 4 | 4 | None | $233 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Dbs | $332 | 7 payments
|
| Ucb | Fintepla | $32 | 1 payment
|
| SK Life Science | None | $22 | 1 payment
|
See all 9 published payments
| Ucb | Meals · 2025-06-05 | Fintepla | $32 |
| Boston Scientific | Meals · 2025-06-03 | General - Dbs | $60 |
| Boston Scientific | Meals · 2025-05-06 | General - Dbs | $45 |
| SK Life Science | Meals · 2025-04-30 | None | $22 |
| Boston Scientific | Meals · 2025-04-09 | General - Dbs | $52 |
| Boston Scientific | Meals · 2025-04-01 | General - Dbs | $57 |
| Boston Scientific | Meals · 2025-03-04 | Vercise | $39 |
| Boston Scientific | Meals · 2025-02-04 | Vercise | $40 |
| Boston Scientific | Meals · 2025-01-07 | Vercise | $39 |
See earlier years (2024, 2022, 2021)
2024: $287
| Boston Scientific | Vercise | $260 | 6 payments
|
| Nevro | Senza | $27 | 1 payment
|
2022: $43
| Medtronic | Percept PC Brainsense | $27 | 1 payment
|
| NuVasive | Alif | $16 | 1 payment
|
2021: $233
| Stryker | Trevo | $163 | 1 payment
|
| Ucb | Briviact | $25 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $24 | 1 payment
|
| Novocure | Optune | $22 | 1 payment
|
Professional record
- NPI
- 1629508924
- Licence
- CA 95016482
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-06-19
- NPI last updated
- 2026-01-28
- NPI record certified
- 2026-01-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 130 E 77th St, New York, NY, 10075 · 169 W 133rd St, New York, NY, 10030 · 1100 Van Ness Ave, San Francisco, CA, 94109